Client Story
Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions
This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for global trials. The document highlights how professional language services, such as those provided by TransPerfect Life Sciences, can offer solutions to ensure accurate and effective implementation of COAs, overcoming challenges related to translation and localization in pharmaceutical research and development.
